Pain Therapeutics reported $23.35M in Current Assets for its second fiscal semester of 2019.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US $ 47.8M 823K
Amgen AMGN:US $ 21144M 1517M
Biodelivery Sciences International BDSI:US $ 168.65M 9.64M
Biogen BIIB:US $ 6887.1M 956M
Cara Therapeutics CARA:US $ 132.84M 9.08M
Eisai 4523:JP Y 495618M 8901M
Geron GERN:US $ 231.86M 11.12M
Novartis NOVN:VX 29.67B 5.79B
Novavax NVAX:US $ 671.22M 34.84M